TIDMMEDG 
 
RNS Number : 6704M 
Medgenics Inc 
03 February 2009 
 

Medgenics, Inc. 
('Medgenics' or the 'Company') 
 
 
 
 
3 February 2009 
 
 
The Board of Medgenics announces that it was informed on 30 January 2009 that, 
on that same day, pursuant to the warrant repricing programme announced on 17 
December 2008, Lord Leonard Steinberg (a Director of the Company) exercised 
4,000,000 warrants at the reduced exercise price of $0.0375 each (the "Reduced 
Warrant Price") which entitled him to 4,000,000 ordinary shares of 
US $0.0001 each ("Ordinary Shares") and warrants to purchase 450,000 Ordinary 
Shares. The warrants ("Bonus Warrants") are exercisable from 30/1/09 and expire 
on 30/12/12 at an exercise price US $0.25 per Ordinary Share. The total cost of 
this exercise was $150,000. 
 
 
The Company is also pleased to announce that it was also informed on 30 January 
2009 that, on that same day, Joel Kanter (also a director of the Company) and 
his affiliated interests have exercised 4,000,000 warrants at the Reduced 
Warrant Price, in order to acquire 4,000,000 Common Shares and 450,000 Bonus 
Warrants for total consideration of US $150,000. These warrants exercised were 
held by CIBC Trust Company (Bahamas) Limited, as Trustee of T-555*. 
 
 
Pursuant to Rule 21 of the AIM Rules for Companies, Lord Leonard Steinberg and 
Joel Kanter declared binding commitments to these warrant exercises which were 
notified on 17 December 2008. 
 
 
The Board is also very pleased to announce that a further 2,637,578 warrants 
have been exercised at the Reduced Warrant Price resulting in the issues of 
2,637,578 Ordinary Shares and 296,728 Bonus Warrants. This has resulted in total 
consideration (including the investments by Lord Leonard Steinberg and Joel 
Kanter) received by the Company as a result of the warrant repricing programme 
of US$ $398,909. 
 
 
These new Ordinary Shares will be admitted to AIM pursuant to the block listing 
which was applied for on 4 December 2007 and will trade under the TIDM (ticker) 
MEDG. The Company announces that, as at the date of this announcement, it has 
117,365,773 Ordinary Shares in issue. 
 
 
Following the above warrant conversions, Lord Leonard Steinberg and Joel Kanter 
are interested in the following number of Ordinary Shares: 
 
 
+-----------------------------------------+----------------+----------------+ 
| Name                                    |     Number of  |    % of Issued | 
|                                         |  Common Shares |  Share Capital | 
+-----------------------------------------+----------------+----------------+ 
| Lord Leonard Steinberg                  |     18,484,725 |          15.7% | 
+-----------------------------------------+----------------+----------------+ 
| Joel Kanter *                           |     12,998,556 |          11.1% | 
+-----------------------------------------+----------------+----------------+ 
 
 
Notes: 
*Included in the interests of Joel Kanter are his interests in: 
 
(i) 949,226 Common Shares held by the Kanter Family Foundation, an Illinois 
not-for-profit corporation of which Mr. Kanter is the President and is a 
Director; 
(ii)7,605,985 Common Shares held by CIBC Trust Company (Bahamas) Limited 
("CIBC"). CIBC is the trustee of Settlement T-555 (the "CIBC Trust"). The CIBC 
Trust was established for the benefit of various descendants of (i) Helen and 
Henry Krakow, and (ii) Beatrice and Morris Kanter. Mr. Kanter is a discretionary 
beneficiary of the CIBC Trust. Sole voting and investment control of the Common 
Shares owned by the CIBC Trust is vested in CIBC as trustee of the CIBC Trust; 
(iii) 4,400,807 Common Shares held by Chicago Investments, Inc. ("CII"). CII is 
a majority-owned subsidiary of Chicago Holdings, Inc. ("CHI"). CHI is majority 
owned by various trusts (together the "Kanter Trusts") established for the 
benefit of various descendants of (i) Helen and Henry Krakow, and (ii) Beatrice 
and Morris Kanter. Joel Kanter is a discretionary beneficiary of some, but not 
all, of the Kanter Trusts. Sole voting and investment control of the Common 
Shares owned by CII is vested in Mr. Kanter's brother, Joshua Kanter, as 
President of CII; and 
(iv)42,548 Common Shares held by Chicago Private Investments, Inc ("CPI"). CPI 
is a wholly owned subsidiary of The Holding Company ("THC"). THC is owned by 
Kanter Trusts. Sole voting and investment control of the shares of the Company 
owned by CPI is vested in Mr. Kanter's brother, Joshua Kanter, as President of 
CPI. 
For the purposes of applicable US Securities Laws and regulations, Mr. Kanter 
disclaims all beneficial and pecuniary interest to the Common Shares held by CII 
and CPI and the CIBC Trust. Such disclaimer does not affect Mr. Kanter's status 
as a discretionary beneficiary under the Kanter Trusts or the CIBC Trust. 
 
 
 
 
 
Following the Transaction, Lord Leonard Steinberg and Joel Kanter are interested 
in the following number of warrants: 
 
 
+-----------+----------+-------------+----------+----------+----------+ 
| Name      |  Warrant |      Number |    Issue |   Expiry | Exercise | 
+-----------+----------+-------------+----------+----------+----------+ 
|           |     Name |             |     date |     date |    price | 
+-----------+----------+-------------+----------+----------+----------+ 
|           |          |             |          |          |      US$ | 
+-----------+----------+-------------+----------+----------+----------+ 
|           |          |             |          |          |          | 
+-----------+----------+-------------+----------+----------+----------+ 
| Lord      |        W |     832,423 |  4/12/07 |  4/12/12 |    0.194 | 
| Leonard   |          |             |          |          |          | 
+-----------+----------+-------------+----------+----------+----------+ 
| Steinberg |        W |   1,145,964 |  31/5/07 |  31/5/12 |    0.164 | 
+-----------+----------+-------------+----------+----------+----------+ 
|           |        W |     763,997 |  4/12/07 |  4/12/12 |    0.164 | 
+-----------+----------+-------------+----------+----------+----------+ 
|           |    Bonus |     450,000 |  30/1/09 |  30/1/12 |    0.025 | 
+-----------+----------+-------------+----------+----------+----------+ 
|      -------------------------------------------------------------- | 
+---------------------------------------------------------------------+ 
|           |          |   3,192,384 |          |          |          | 
+-----------+----------+-------------+----------+----------+----------+ 
|           |          |             |          |          |          | 
+-----------+----------+-------------+----------+----------+----------+ 
|           |          |             |          |          |          | 
+-----------+----------+-------------+----------+----------+----------+ 
| Joel      |        W |   3,059,192 |  31/3/06 |  31/3/11 |    0.071 | 
+-----------+----------+-------------+----------+----------+----------+ 
| Kanter    |        W |   1,069,575 | 23/10/06 | 23/10/11 |    0.117 | 
+-----------+----------+-------------+----------+----------+----------+ 
|           |        W |     857,007 | 23/10/06 | 23/10/11 |    0.117 | 
+-----------+----------+-------------+----------+----------+----------+ 
|           |       RW |     197,914 |  31/3/06 |  31/3/11 | 0.000005 | 
+-----------+----------+-------------+----------+----------+----------+ 
|           |       RS |  14,080,734 |  31/3/06 |  31/3/11 | 0.023634 | 
+-----------+----------+-------------+----------+----------+----------+ 
|           |    Bonus |     450,000 |  30/1/09 |  30/1/12 |    0.025 | 
+-----------+----------+-------------+----------+----------+----------+ 
|      -------------------------------------------------------------- | 
+---------------------------------------------------------------------+ 
|           |          | 19,714,422  |          |          |          | 
+-----------+----------+-------------+----------+----------+----------+ 
 
 
The current warrants outstanding in the Company are as follows: 
 
 
+----------+-------------+-------------+-----------+-----------+ 
| Warrant  |        Date |      No. of |           |    Expiry | 
|          |          of |             |  Exercise |      Date | 
+----------+-------------+-------------+-----------+-----------+ 
| Type     |       Issue |     Common  |     Price |           | 
|          |             |             |       per |           | 
+----------+-------------+-------------+-----------+-----------+ 
|          |             |      Shares | Common    |           | 
+----------+-------------+-------------+-----------+-----------+ 
|          |             |             |     Share |           | 
+----------+-------------+-------------+-----------+-----------+ 
| RS       |    31.03.06 |  15,680,818 |        US |  31.03.11 | 
|          |             |             |   $0.0005 |           | 
+----------+-------------+-------------+-----------+-----------+ 
| RS       |    31.03.06 |  36,481,902 |        US |  31.03.11 | 
|          |             |             |    $0.071 |           | 
+----------+-------------+-------------+-----------+-----------+ 
| RW       |    31.03.06 |   1,586,735 |        US |  31.03.11 | 
|          |             |             | $0.000005 |           | 
+----------+-------------+-------------+-----------+-----------+ 
| RW       |    22.10.08 |      22,588 |        US |  31.03.11 | 
|          |             |             | $0.000005 |           | 
+----------+-------------+-------------+-----------+-----------+ 
| X        |    31.03.06 |   4,278,298 |        US |  24.03.10 | 
|          |             |             |    $0.071 |           | 
+----------+-------------+-------------+-----------+-----------+ 
| X        |    31.03.06 |     533,183 |        US |  31.03.11 | 
|          |             |             |    $0.071 |           | 
+----------+-------------+-------------+-----------+-----------+ 
| W        |    31.03.06 |  21,397,303 |        US |  31.03.11 | 
|          |             |             |    $0.071 |           | 
+----------+-------------+-------------+-----------+-----------+ 
| W        |    10.04.06 |   1,026,792 |        US |  10.04.11 | 
|          |             |             |    $0.071 |           | 
+----------+-------------+-------------+-----------+-----------+ 
| W        |    14.06.06 |   1,069,575 |        US |  14.06.11 | 
|          |             |             |    $0.071 |           | 
+----------+-------------+-------------+-----------+-----------+ 
| W        |    23.10.06 |  19,893,486 |        US |  23.10.11 | 
|          |             |             |    $0.117 |           | 
+----------+-------------+-------------+-----------+-----------+ 
| W        |             |     705,919 |        US |  31.03.11 | 
|          |     9.02.07 |             |    $0.071 |           | 
+----------+-------------+-------------+-----------+-----------+ 
| W        |    13.03.07 |     705,919 |        US |  31.03.11 | 
|          |             |             |    $0.071 |           | 
+----------+-------------+-------------+-----------+-----------+ 
| W        |    13.03.06 |   2,117,758 |        US |  21.06.11 | 
|          |             |             |    $0.071 |           | 
+----------+-------------+-------------+-----------+-----------+ 
| W        |    13.03.07 |   1,336,968 |        US |  23.10.11 | 
|          |             |             |    $0.117 |           | 
+----------+-------------+-------------+-----------+-----------+ 
| W        |    31.05.07 |   1,329,310 |        US |  31.05.12 | 
|          |             |             |    $0.164 |           | 
+----------+-------------+-------------+-----------+-----------+ 
| W        |             |     402,246 |        US |  13.08.12 | 
|          |    13.08.07 |             |    $0.164 |           | 
+----------+-------------+-------------+-----------+-----------+ 
| W        |    17.08.07 |      64,174 |        US |  17.08.12 | 
|          |             |             |    $0.164 |           | 
+----------+-------------+-------------+-----------+-----------+ 
| W        |     4.12.07 |     252,334 |        US |  13.08.12 | 
|          |             |             |    $0.164 |           | 
+----------+-------------+-------------+-----------+-----------+ 
| W        |             |   1,259,810 |        US |   4.12.12 | 
|          |     4.12.07 |             |    $0.164 |           | 
+----------+-------------+-------------+-----------+-----------+ 
| W        |     4.12.07 |   2,997,420 |        US |   4.12.12 | 
|          |             |             |    $0.194 |           | 
+----------+-------------+-------------+-----------+-----------+ 
| W        |     4.12.07 |     570,992 |       10p | 4.12.12   | 
+----------+-------------+-------------+-----------+-----------+ 
| W        |    19.10.08 |     305,598 |        US |  17.08.12 | 
|          |             |             |    $0.164 |           | 
+----------+-------------+-------------+-----------+-----------+ 
| Platinum |    13.08.07 |   1,909,619 |        US |  31.08.12 | 
|          |             |             |    $0.164 |           | 
+----------+-------------+-------------+-----------+-----------+ 
| Platinum |     4.12.07 |   1,604,362 |        US |   4.12.12 | 
|          |             |             |    $0.164 |           | 
+----------+-------------+-------------+-----------+-----------+ 
| Platinum |     4.12.07 |      23,183 |       10p |   4.12.12 | 
+----------+-------------+-------------+-----------+-----------+ 
| Platinum |     1.12.08 |   2,353,064 |        US |   4.12.13 | 
|          |             |             |    $0.194 |           | 
+----------+-------------+-------------+-----------+-----------+ 
| Bonus    |     30.1.09 |   1,196,728 |        US |   30.1.12 | 
|          |             |             |    $0.025 |           | 
+----------+-------------+-------------+-----------+-----------+ 
|          |             |             |           |           | 
+----------+-------------+-------------+-----------+-----------+ 
| Total    | 121,106,081 |             |           |           | 
+----------+-------------+-------------+-----------+-----------+ 
 
 
 
 
For further information, contact: 
 
 
+-----------------------------------+------------------------+ 
| Medgenics, Inc.                   | +972 4 902 8900        | 
+-----------------------------------+------------------------+ 
| Dr. Andrew L. Pearlman            |                        | 
+-----------------------------------+------------------------+ 
|                                   |                        | 
+-----------------------------------+------------------------+ 
| Blomfield Corporate Finance       | +44 207 489 4500       | 
+-----------------------------------+------------------------+ 
| James Pinner or                   |                        | 
+-----------------------------------+------------------------+ 
| Alan MacKenzie                    |                        | 
+-----------------------------------+------------------------+ 
|                                   |                        | 
+-----------------------------------+------------------------+ 
| SVS Securities plc                | +44 207 638 5600       | 
+-----------------------------------+------------------------+ 
| Peter Manfield or                 |                        | 
+-----------------------------------+------------------------+ 
| Ian Callaway                      |                        | 
+-----------------------------------+------------------------+ 
|                                   |                        | 
+-----------------------------------+------------------------+ 
| Grayling Global                   | +44 207 255 5406       | 
+-----------------------------------+------------------------+ 
| Jonathan Shillington or           |                        | 
+-----------------------------------+------------------------+ 
| Alistair Scott                    |                        | 
+-----------------------------------+------------------------+ 
 
 
 
This information is provided by RNS 
            The company news service from the London Stock Exchange 
   END 
 
 RDSTTMPTMMTMBIL 
 

Medgenics(Regs) (LSE:MEDG)
Historical Stock Chart
From Jun 2024 to Jul 2024 Click Here for more Medgenics(Regs) Charts.
Medgenics(Regs) (LSE:MEDG)
Historical Stock Chart
From Jul 2023 to Jul 2024 Click Here for more Medgenics(Regs) Charts.